Literature DB >> 2849947

Inhibition and labeling of the rat renal Na+/H+-exchanger by an antagonist of muscarinic acetylcholine receptors.

T Friedrich1, G Burckhardt.   

Abstract

A covalently binding label for muscarinic acetylcholine receptors, propylbenzilylcholine mustard (PrBCM), irreversibly inhibits the Na+/H+ exchanger in rat renal brush-border membrane vesicles. Substrates of the antiporter, Na+ and Li+, as well as inhibitors, amiloride, 5-(N-ethyl-N-isopropyl)amiloride (EIPA) and propranolol, protect the antiporter from inactivation by PrBCM. With [3H]PrBCM a band with an app. Mr of 65 kDa is predominantly labeled. Amiloride protects this band from labeling with [3H]PrBCM and [14C]-N,N'-dicyclohexylcarbodiimide (DCCD) proving its identity with the renal Na+/H+ exchanger. Our data reveal a specific interaction of PrBCM with the Na+/H+ exchanger and suggest structural relations between antiporter and receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849947     DOI: 10.1016/s0006-291x(88)80962-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Aldosterone actions on basolateral Na+/H+ exchange in Madin-Darby canine kidney cells.

Authors:  S Vilella; L Guerra; C Helmle-Kolb; H Murer
Journal:  Pflugers Arch       Date:  1992-10       Impact factor: 3.657

2.  Relative sensitivity to inhibition by cimetidine and clonidine differentiates between the two types of Na(+)-H+ exchangers in cultured cells.

Authors:  S Ramamoorthy; C Tiruppathi; C N Nair; V B Mahesh; F H Leibach; V Ganapathy
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

3.  Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systems. I. Amines, piperidines, piperazines, azepines, pyridines, quinolines, imidazoles, thiazoles, guanidines and hydrazines.

Authors:  K J Ullrich; G Rumrich; C David; G Fritzsch
Journal:  Pflugers Arch       Date:  1993-11       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.